Monte Rosa Therapeutics
GLUE
#6712
Rank
ยฃ0.56 B
Marketcap
ยฃ6.60
Share price
-3.03%
Change (1 day)
-39.18%
Change (1 year)

Earnings for Monte Rosa Therapeutics (GLUE)

Earnings in 2026 (TTM): -ยฃ97.53 Million

According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are ยฃ70.32 Million. In 2025 the company made an earning of -ยฃ30.37 Million, an increase over its 2024 earnings that were of -ยฃ53.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monte Rosa Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ97.53 Million221.17%
2025 -ยฃ30.37 Million-43.36%
2024 -ยฃ53.61 Million-48.06%
2023 -ยฃ0.11 Billion24.43%
2022 -ยฃ82.95 Million46.71%
2021 -ยฃ56.54 Million106.13%
2020 -ยฃ27.43 Million